|
Sign In to gain access to subscriptions and/or personal tools.
|
The Pickering Lecture British Hypertension Society, 10th September 2002Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease
David G Harrison
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA, dharr02{at}emory.edu
Hua Cai
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA
Ulf Landmesser
Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany
Kathy K Griendling
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA
An elevation in angiotensin II (Ang II) levels is a common occurrence in a diverse number of cardiovascular diseases including hypertension, hypercholesterolaemia, atherosclerotic coronary artery disease, left ventricular hypertrophy (LVH), heart failure and diabetes. An important effect of Ang II is activation of the NAD(P)H oxidase, a major source of reactive oxygen species (ROS) production by vascular cells. This increase in cellular ROS contributes to the pathogenesis of vascular disease by altering endothelial cell function, enhancing smooth muscle cell growth and proliferation, stimulating inflammatory proteins, including macrophage chemoattractant agents, growth factors and cytokines, and modulating matrix remodelling. Studies of genetically-altered mice have unequivocally shown that activation of the NAD(P)H oxidase by Ang II contributes to hypertension, LVH and atherosclerosis. Furthermore, increasing evidence suggest that the NAD(P)H oxidase contributes to human disease, suggesting that it is a potential target for future therapeutic intervention.
Key Words: angiotensin II • reactive oxygen species • vascular disease • NAD(P)H oxidase
References
- Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 1999;893:13-18.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McCord JM, Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 1988;5:363-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Thomson L., Trujillo M., Telleri R., Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys 1995;319:491-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- O'Donnell VB, Chumley PH, Hogg N., Bloodsworth A., Darley-Usmar VM, Freeman BA Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry 1997;36:15216-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tanner FC, Noll G., Boulanger CM, Luscher TF Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83:2012-20.[Abstract/Free Full Text]
- Pieper GM, Langenstroer P., Siebeneich W.. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997;34:145-56.[Abstract/Free Full Text]
- Brennan ML, Wu W., Fu X. et al.A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002;277:17415-27.[Abstract/Free Full Text]
- Baldus S., Eiserich JP, Brennan ML, Jackson RM, Alexander CB, Freeman BA Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 2002;33:1010.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Eiserich JP, Baldus S., Brennan ML et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296: 2391-4.[Abstract/Free Full Text]
- Cai H., Harrison DG Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-4.[Abstract/Free Full Text]
- Harrison DG Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997;100:2153-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Herbst U., Toborek M., Kaiser S., Mattson MP, Hennig B. 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J Cell Physiol 1999;181:295-303.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Marklund SL Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984;74:1398-403.[Web of Science][Medline]
[Order article via Infotrieve]
- Karlsson K., Marklund SL Extracellular superoxide dismutase in the vascular system of mammals. Biochem J 1988;255:223-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Bjornstedt M., Hamberg M., Kumar S., Xue J., Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 1995;270:11761-4.[Abstract/Free Full Text]
- Zhong L., Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 2000;275:18121-8.[Abstract/Free Full Text]
- Nordberg J., Arner ES Reactive oxygen species, antioxidants, and the mammalian Ithioredoxin system. Free Radic Biol Med 2001;31:1287-312.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Griendling KK, Sorescu D., Lassegue B., Ushio-Fukai M. Modulation of protein kinase activity and gene expression by Areactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20:2175-83.[Abstract/Free Full Text]
- Hayes GR, Lockwood DH Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci USA 1987;84:8115-19.[Abstract/Free Full Text]
- Sullivan SG, Chiu DT, Errasfa M., Wang JM, Qi JS, Stern A. Effects of H2O2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic Biol Med 1994;16:399-403.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sundaresan M., Yu ZX, Ferrans VJ, Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995;270:296-9.[Abstract/Free Full Text]
- Abe J., Takahashi M., Ishida M., Lee JD, Berk BC c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem 1997;272:20389-94.[Abstract/Free Full Text]
- Ushio-Fukai M.,Alexander RW,Akers M., Griendling KK p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998;273:15022-9.[Abstract/Free Full Text]
- Yoshizumi M.,Abe J., Haendeler J., Huang Q., Berk BC Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000;275:11706-12.[Abstract/Free Full Text]
- Cai H., Li Z., Davis ME, Kanner W., Harrison DG, Dudley SC, Jr. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol 2003;63:325-31.[Abstract/Free Full Text]
- Bae YS, Kang SW, Seo MS et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997;272:217-21.[Abstract/Free Full Text]
- Simon AR, Rai U., Fanburg BL, Cochran BH Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998;275(6 Pt 1):C1640-52.[Web of Science][Medline]
[Order article via Infotrieve]
- Ushio-Fukai M., Alexander RW, Akers M. et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999;274:22699-704.[Abstract/Free Full Text]
- Konishi H., Tanaka M., Takemura Y. et al. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 1997;94:11233-7.[Abstract/Free Full Text]
- Lander HM, Ogiste JS, Teng KK, Novogrodsky A. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 1995;270:21195-8.[Abstract/Free Full Text]
- Mohazzab HK, Agarwal R., Wolin MS Influence of glutathione peroxidase on coronary artery responses to alterations in PO2 and H2O2. Am J Physiol 1999;276(1 Pt 2):H235-41.[Web of Science][Medline]
[Order article via Infotrieve]
- Cai H., Li Z., Dikalov S. et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002;277:48311-17.[Abstract/Free Full Text]
- Thomas SR, Chen K., Keaney JF, Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 2002;277:6017-24.[Abstract/Free Full Text]
- Somers MJ, Burchfield JS, Harrison DG Evidence for a NADH/NADPH oxidase in human umbilical vein endothelial cells using electron spin resonance. Antioxid Redox Signal 2000;2:779-87.[Medline]
[Order article via Infotrieve]
- Sorescu D., Somers MJ, Lassegue B., Grant S., Harrison DG, Griendling KK Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med 2001;30:603-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Suh YA,Arnold RS, Lassegue B. et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401:79-82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lassegue B., Sorescu D., Szocs K. et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88:888-94.[Abstract/Free Full Text]
- Sorescu D., Weiss D., Lassegue B. et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-35.[Abstract/Free Full Text]
- Banfi B., Molnar G., Maturana A. et al. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 2001;276:37594-601.[Abstract/Free Full Text]
- Banfi B., Clark RA, Steger K., Krause KH Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 2003;278:3510-13.[Abstract/Free Full Text]
- Hilenski LL, Clempus RE, Griendling KK NAD(P)H oxidase subunits Nox1 and Nox4 are differentially localized in the membrane and in focal adhesions in vascular smooth muscle cells. Circulation 2002;106(suppl 19):283.[Free Full Text]
- Hanna IR, Dikalova A., Hilenski LL, Quinn MT, Griendling KK Nox1 binds p22phox to form a functional oxidase in vascular smooth muscle cells (VSMCs). Circulation 2002;106(19 suppl):164.[Free Full Text]
- Holland JA, Meyer JW, Chang MM, O'Donnell RW, Johnson DK, Ziegler LM Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium 1998;6:113-21.[Medline]
[Order article via Infotrieve]
- Marumo T., Schini-Kerth VB, Fisslthaler B., Busse R. Plateletderived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 1997;96:2361-7.[Abstract/Free Full Text]
- De Keulenaer GW, Alexander RW, Ushio-Fukai M., Ishizaka N., Griendling KK Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998;329(Pt 3):653-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Bhunia AK, Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem 1997; 272:15642-9.[Abstract/Free Full Text]
- De Keulenaer GW, Chappell DC, Ishizaka N., Nerem RM, Alexander RW, Griendling KK Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998; 82:1094-101.[Abstract/Free Full Text]
- Hishikawa K., Oemar BS, Yang Z., Luscher TF Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res 1997;81:797-803.[Abstract/Free Full Text]
- Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR Cyclic strain induces an oxidative stress in endothelial cells. AmJPhysiol 1997;272(2 Pt 1):C421-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Oeckler RA, Kaminski PM, Wolin MS Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 2003;92:23-31.[Abstract/Free Full Text]
- Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.[Abstract/Free Full Text]
- Seshiah PN, Weber DS, Rocic P., Valppu L., Taniyama Y., Griendling KK Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002;91:406-13.[Abstract/Free Full Text]
- Touyz RM, Chen X.,Tabet F. et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002;90:1205-13.[Abstract/Free Full Text]
- Lavigne MC, Malech HL, Holland SM, Leto TL Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001;104:79-84.[Abstract/Free Full Text]
- Landmesser U., Cai H., Dikalov S. et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002;40:511-15.[Abstract/Free Full Text]
- Li JM, Shah AM Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: Role of the p47phox subunit. J Biol Chem 2003;30:30.
- Touyz RM, Yao G., Schiffrin EL c-Src Induces Phosphorylation and Translocation of p47phox. Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 2003; 27:27.
- Fukui T., Ishizaka N., Rajagopalan S. et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997;80:45-51.[Abstract/Free Full Text]
- Mollnau H., Wendt M., Szocs K. et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:E58-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ushio-Fukai M., Zafari AM, Fukui T., Ishizaka N., Griendling KK p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317-21.[Abstract/Free Full Text]
- Zafari AM, Ushio-Fukai M., Akers M. et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998;32:488-95.[Abstract/Free Full Text]
- Frank GD, Eguchi S., Yamakawa T., Tanaka S., Inagami T., Motley ED Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 2000;141:3120-6.[Abstract/Free Full Text]
- Tummala PE, Chen XL, Sundell CL et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999;100:1223-9.[Abstract/Free Full Text]
- Schieffer B., Luchtefeld M., Braun S. et al. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 2000;87:1195-201.[Abstract/Free Full Text]
- Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998;83:952-9.[Abstract/Free Full Text]
- Fan J., Frey RS, Rahman A., Malik AB Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha-induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002;277:3404-11.[Abstract/Free Full Text]
- Gu Y., Xu YC, Wu RF et al. p47phox participates in activation of RelA in endothelial cells. J Biol Chem 2003;4:4.
- Ushio-Fukai M., Tang Y., Fukai T. et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160-7.[Abstract/Free Full Text]
- Ushio-Fukai M., Griendling KK, Becker PL, Hilenski L., Halleran S., Alexander RW Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:489-95.[Abstract/Free Full Text]
- Page EL, Robitaille GA, Pouyssegur J., Richard DE Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002;277:48403-9.[Abstract/Free Full Text]
- Saito S., Hirata Y., Emori T., Imai T., Marumo F. Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens Res 1996;19:201-06.[Medline]
[Order article via Infotrieve]
- Pueyo ME,Arnal JF, Rami J., Michel JB.Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998;274(1 Pt 1):C214-20.[Web of Science][Medline]
[Order article via Infotrieve]
- Thorup C., Kornfeld M., Goligorsky MS, Moore LC AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries. J Am Soc Nephrol 1999; 10(suppl 11):S220-4.[Web of Science][Medline]
[Order article via Infotrieve]
- Rajagopalan S., Kurz S., Munzel T. et al.Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.[Web of Science][Medline]
[Order article via Infotrieve]
- Cifuentes ME, Rey FE, Carretero OA, Pagano PJ Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 2000;279:H2234-40.[Abstract/Free Full Text]
- Laursen JB, Rajagopalan S., Galis Z.,Tarpey M., Freeman BA, Harrison DG Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997;95:588-93.[Abstract/Free Full Text]
- Brandes RP, Viedt C., Nguyen K. et al. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost 2001;85:1104-10.[Web of Science][Medline]
[Order article via Infotrieve]
- Zalba G., Beaumont FJ, San Jose G. et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000;35:1055-61.[Abstract/Free Full Text]
- Landmesser U., Dikalov S., Price SR et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111:1201-09.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cosentino F., Katusic ZSTetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 1995;91:139-44.[Abstract/Free Full Text]
- Hink U., Li H., Mollnau H. et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88:E14-22.[Web of Science][Medline]
[Order article via Infotrieve]
- Shinozaki K., Hirayama A., Nishio Y. et al. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 2001;38:1821-8.[Abstract/Free Full Text]
- Zimmerman MC, Lazartigues E., Lang JA et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002;91:1038-45.[Abstract/Free Full Text]
- Li Z., Mao HZ,Abboud FM, Chapleau MW Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 1996;79:802-11.[Abstract/Free Full Text]
- Jones SA, HancockJT,Jones OT, NeubauerA.,Topley N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 1995;5:1483-91.[Abstract]
- Shiose A., Kuroda J.,Tsuruya K. et al.A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001; 276:1417-23.[Abstract/Free Full Text]
- Warnholtz A., Nickenig G., Schulz E. et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the reninangiotensin system. Circulation 1999;99:2027-33.[Abstract/Free Full Text]
- Guzik TJ, West NE, Black E. et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000;86:E85-90.[Web of Science][Medline]
[Order article via Infotrieve]
- Barry-Lane PA, Patterson C., van der Merwe M. et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001;108:1513-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Miller FJ Jr., Sharp WJ, Fang X., Oberley LW, Oberley TD, Weintraub NL Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 2002;22:560-5.[Abstract/Free Full Text]
- Spiekermann S., Landmesser U., Dikalov S. et al. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003;107:1383-9.[Abstract/Free Full Text]
- Bauersachs J., Bouloumie A., Fraccarollo D., Hu K., Busse R., Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999;100:292-8.[Abstract/Free Full Text]
- Munzel T., Sayegh H., Freeman BA,Tarpey MM, Harrison DG Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-94.[Web of Science][Medline]
[Order article via Infotrieve]
- Kurz S., Hink U., Nickenig G., Borthayre AB, Harrison DG, Munzel T. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance. Circulation 1999;99:3181-7.[Abstract/Free Full Text]
- Gey KF, Puska P., Jordan P., Moser UK Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53(suppl 1):326S-334S.[Medline]
[Order article via Infotrieve]
- Salonen RM, Nyyssonen K., Kaikkonen J. et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003; 107:947-53.[Abstract/Free Full Text]
- Stephens NG, Parsons A., Schofield PM, Kelly F., Cheeseman K., Mitchinson MJ Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fang JC, Kinlay S., Beltrame J. et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002;359:1108-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lonn E., Yusuf S., Dzavik V. et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919-25.[Abstract/Free Full Text]
- Marchioli R., Barzi F., Bomba E. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Pr I evenzione. Circulation 2002;105:1897903.
- Group Hpsc. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jiang Q., Christen S., Shigenaga MK, Ames BN Gammatocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001;74:714-22.[Abstract/Free Full Text]
- Tribble DL, Gong EL, Leeuwenburgh C. et al. Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase. Arterioscler Thromb Vasc Biol 1997;17:173440.
- Johnson DK, Schillinger KJ, Kwait DM et al. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 2002;9:191-203.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Diatchuk V., Lotan O., Koshkin V., Wikstroem P., Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 1997;272:13292-301.[Abstract/Free Full Text]
- Cayatte AJ, Rupin A., Oliver-Krasinski J. et al. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase. Arterioscler Thromb Vasc Biol 2001;21:1577-84.[Abstract/Free Full Text]
- WangYX, Poon CI, Poon KS, Pang CC Inhibitory actions of diphenyleneiodonium on endothelium-dependent vasodilatations in vitro and in vivo. BrJPharmacol 1993;110:1232-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Warnholtz A., Nickenig G., Schulz E. et al. Increased NADHoxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999;99:2027-33.[Abstract/Free Full Text]
- Vecchione C., Brandes RP Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 2002;91:173-9.[Abstract/Free Full Text]
- Horiuchi M., Cui TX, Li Z., Li JM, Nakagami H., Iwai M. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. Circulation 2003;107:106-12.[Abstract/Free Full Text]
- Tardif JC, Gregoire J., Schwartz L. et al. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 2003;107:552-8.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 4, No. 2,
51-61 (2003)
DOI: 10.3317/jraas.2003.014
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
B. T. Larsen, A. H. Bubolz, S. A. Mendoza, K. A. Pritchard Jr, and D. D. Gutterman
Bradykinin-Induced Dilation of Human Coronary Arterioles Requires NADPH Oxidase-Derived Reactive Oxygen Species
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
739 - 745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Stewart, A. J. Ocon, D. Clarke, I. Taneja, and M. S. Medow
Defects in Cutaneous Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Production in Postural Tachycardia Syndrome
Hypertension,
May 1, 2009;
53(5):
767 - 774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zhang, P. Harding, J. L. Garvin, R. Juncos, E. Peterson, L. A. Juncos, and R. Liu
Isoforms and Functions of NAD(P)H Oxidase at the Macula Densa
Hypertension,
March 1, 2009;
53(3):
556 - 563.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, S. Yang, S. Hu, M. A. Choudhry, K. I. Bland, and I. H. Chaudry
Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor
Am J Physiol Gastrointest Liver Physiol,
November 1, 2008;
295(5):
G1131 - G1137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Monassier, M.-A. Laplante, F. Jaffre, P. Bousquet, L. Maroteaux, and J. de Champlain
Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species-Induced Cardiac Hypertrophy in Mice
Hypertension,
August 1, 2008;
52(2):
301 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Stewart, I. Taneja, N. Raghunath, D. Clarke, and M. S. Medow
Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response
Am J Physiol Heart Circ Physiol,
July 1, 2008;
295(1):
H327 - H334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Stewart, I. Taneja, J. Glover, and M. S. Medow
Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome
Am J Physiol Heart Circ Physiol,
January 1, 2008;
294(1):
H466 - H473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2009 - H2023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Muthumala, H. Montgomery, J. Palmen, J. A. Cooper, and S. E. Humphries
Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men
Hypertension,
August 1, 2007;
50(2):
348 - 353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Whaley-Connell, G. Govindarajan, J. Habibi, M. R. Hayden, S. A. Cooper, Y. Wei, L. Ma, M. Qazi, D. Link, P. R. Karuparthi, et al.
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E355 - E363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Nouri, P. Gill, M. Li, C. S. Wilcox, and W. J. Welch
p22phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats
Am J Physiol Heart Circ Physiol,
April 1, 2007;
292(4):
H1685 - H1689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Just, A. J. M. Olson, C. L. Whitten, and W. J. Arendshorst
Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H83 - H92.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen and J. L. Mehta
Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1738 - H1745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-D. Lee, C.-H. Chu, E.-J. Huang, M.-C. Lu, J.-Y. Liu, C.-J. Liu, H.-H. Hsu, J. A. Lin, W.-W. Kuo, and C.-Y. Huang
Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation.
Am J Physiol Endocrinol Metab,
August 1, 2006;
291(2):
E306 - E314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Zhao, R. A. Ahokas, K. T. Weber, and Y. Sun
ANG II-induced cardiac molecular and cellular events: role of aldosterone
Am J Physiol Heart Circ Physiol,
July 1, 2006;
291(1):
H336 - H343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Stump, M. T. Hamilton, and J. R. Sowers
Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Mayo Clin. Proc.,
June 1, 2006;
81(6):
796 - 806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li
Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H1136 - H1144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2005;
289(4):
R913 - R935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y Shimoni, D Hunt, M Chuang, K. Y Chen, G Kargacin, and D. L Severson
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat
J. Physiol.,
August 15, 2005;
567(1):
177 - 190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chalupsky and H. Cai
Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase
PNAS,
June 21, 2005;
102(25):
9056 - 9061.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Bernstein, H. D. Xiao, J. W. Adams, K. Frenzel, P. Li, X. Z. Shen, J. M. Cole, and S. Fuchs
Establishing the Role of Angiotensin-Converting Enzyme in Renal Function and Blood Pressure Control through the Analysis of Genetically Modified Mice
J. Am. Soc. Nephrol.,
March 1, 2005;
16(3):
583 - 591.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Lu, B. G. Helwig, R. J. Fels, S. Parimi, and M. J. Kenney
Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2626 - H2633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, and G. Nickenig
Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout Mice
Circulation,
November 9, 2004;
110(19):
3062 - 3067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chen, J. Chen, D. Li, X. Zhang, and J. L. Mehta
Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts: Modulation by PPAR-{gamma} Ligand Pioglitazone
Hypertension,
November 1, 2004;
44(5):
655 - 661.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fink, K. Laude, L. McCann, A. Doughan, D. G. Harrison, and S. Dikalov
Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay
Am J Physiol Cell Physiol,
October 1, 2004;
287(4):
C895 - C902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Kawada, K. Dennehy, G. Solis, P. Modlinger, R. Hamel, J. T. Kawada, S. Aslam, T. Moriyama, E. Imai, W. J. Welch, et al.
TP receptors regulate renal hemodynamics during angiotensin II slow pressor response
Am J Physiol Renal Physiol,
October 1, 2004;
287(4):
F753 - F759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Zimmerman, E. Lazartigues, R. V. Sharma, and R. L. Davisson
Hypertension Caused by Angiotensin II Infusion Involves Increased Superoxide Production in the Central Nervous System
Circ. Res.,
July 23, 2004;
95(2):
210 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M Ridker, N. J. Brown, D. E. Vaughan, D. G. Harrison, and J. L. Mehta
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Circulation,
June 29, 2004;
109(25_suppl_1):
IV-6 - IV-19.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Li, H. Rayford, and B. D. Uhal
Essential Roles for Angiotensin Receptor AT1a in Bleomycin-Induced Apoptosis and Lung Fibrosis in Mice
Am. J. Pathol.,
December 1, 2003;
163(6):
2523 - 2530.
[Abstract]
[Full Text]
|
|
|
|
|
